- Home
- DERM vs JRS Comparison
DERM vs JRS Comparison
Compare DERM & JRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DERM | JRS |
|---|---|---|
| Founded | 2014 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.4M | 223.9M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | DERM | JRS |
|---|---|---|
| Price | $7.13 | $7.65 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $12.67 | N/A |
| AVG Volume (30 Days) | ★ 101.7K | 54.1K |
| Earning Date | 03-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.87% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $56,134,000.00 | N/A |
| Revenue This Year | $17.48 | N/A |
| Revenue Next Year | $55.83 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.40 | $6.56 |
| 52 Week High | $9.56 | $8.38 |
Technical Indicators
Market Signals| Indicator | DERM | JRS |
|---|---|---|
| Relative Strength Index (RSI) | 36.56 | 35.54 |
| Support Level | $6.77 | $7.55 |
| Resistance Level | $8.02 | $7.94 |
| Average True Range (ATR) | 0.49 | 0.13 |
| MACD | -0.09 | -0.06 |
| Stochastic Oscillator | 8.43 | 11.84 |
Price Performance
Historical ComparisonAbout DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About JRS Nuveen Real Estate Income Fund of Beneficial Interest
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund invests in income-producing common stocks, preferred stocks, convertible preferred stocks, and debt securities issued by real estate companies.